Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2009

The theory of discovering rare variants via DNA sequencing
Michael C. Wendl
Washington University School of Medicine in St. Louis

Richard K. Wilson
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons

Recommended Citation
Wendl, Michael C. and Wilson, Richard K., ,"The theory of discovering rare variants via DNA sequencing."
BMC Genomics. 10,. 485. (2009).
https://digitalcommons.wustl.edu/open_access_pubs/334

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

BMC Genomics

BioMed Central

Open Access

Research article

The theory of discovering rare variants via DNA sequencing
Michael C Wendl* and Richard K Wilson
Address: The Genome Center and Department of Genetics, Washington University, St. Louis MO 63108, USA
Email: Michael C Wendl* - mwendl@wustl.edu; Richard K Wilson - rwilson@wustl.edu
* Corresponding author

Published: 20 October 2009
BMC Genomics 2009, 10:485

doi:10.1186/1471-2164-10-485

Received: 20 March 2009
Accepted: 20 October 2009

This article is available from: http://www.biomedcentral.com/1471-2164/10/485
© 2009 Wendl and Wilson; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract
Background: Rare population variants are known to have important biomedical implications, but
their systematic discovery has only recently been enabled by advances in DNA sequencing. The
design process of a discovery project remains formidable, being limited to ad hoc mixtures of
extensive computer simulation and pilot sequencing. Here, the task is examined from a general
mathematical perspective.
Results: We pose and solve the population sequencing design problem and subsequently apply
standard optimization techniques that maximize the discovery probability. Emphasis is placed on
cases whose discovery thresholds place them within reach of current technologies. We find that
parameter values characteristic of rare-variant projects lead to a general, yet remarkably simple set
of optimization rules. Specifically, optimal processing occurs at constant values of the per-sample
redundancy, refuting current notions that sample size should be selected outright. Optimal projectwide redundancy and sample size are then shown to be inversely proportional to the desired
variant frequency. A second family of constants governs these relationships, permitting one to
immediately establish the most efficient settings for a given set of discovery conditions. Our results
largely concur with the empirical design of the Thousand Genomes Project, though they furnish
some additional refinement.
Conclusion: The optimization principles reported here dramatically simplify the design process
and should be broadly useful as rare-variant projects become both more important and routine in
the future.

Background
Technological developments continue to dramatically
expand the enterprise of DNA sequencing. In particular,
the emergence of so-called "next-generation" instruments
(NGIs) is opening a new chapter of genomic research [1].
If we characterize sequencing economy by the ratio of
project speed to total project cost, NGIs are orders of magnitude superior to their traditional Sanger-based predecessors. Indeed, they are the first systems to demonstrate the

economic feasibility of sequencing individual genomes
on a large scale [2].
Future efforts will undoubtedly use NGIs to address issues
in medical sequencing and personal genomics [3], but
these instruments are also poised for major contributions
at the population level [4,5]. For example, the Thousand
Genomes Project (TGP) is focusing on comprehensive
identification of variants in the human population
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through cohort-level whole-genome sequencing using
NGIs [6,7]. One of its main goals is to discover and characterize rare single nucleotide alleles, basically those
present at minor allele frequencies around 1% or less. This
region was not accessible to the earlier HapMap Project
[8]. Rarer instances are obviously much more difficult to
find and necessitate gathering enormously larger amounts
of data. Such demands will obviously extend to any future
such projects one might envision, including those for
model organisms, agriculturally important species, cancer
genomes, infectious agents, etc.
The success of such variation projects depends upon adequately understanding the relevant process engineering
issues and subsequently crafting a suitable project design.
One concern in traditional single-genome sequencing is
the so-called "stopping problem" [9-11], which is the
proposition of estimating what redundancy will suffice
for a desired level of genomic coverage. Variation projects
similarly require specification of a total, project-wide
redundancy, R. Yet, because they necessarily involve multiple genomes, an essentially new design question also
emerges. That is, how does one optimize the number of
samples, σ, versus the redundancy allotted per sample, ρ,
such that the probability of finding a rare variant, Pv, is
maximized? The existence of such optima is intuitively
clear. Heavily sequencing only a few samples will tend to
miss a variant because it is unlikely to be present in the
original sample set. Conversely, light sequencing of too
many samples may overlook the variant by virtue of insufficient coverage for any samples actually harboring it.
Somewhere between these extremes lie optimum combinations of parameters.
At present, this issue can only be addressed in ad hoc, fairly
inefficient ways. For example, the TGP conducted both
painstaking computer simulations and pilot sequencing
phases involving hundreds of genomes to aid in designing
the full-scale project [6,7]. While certainly informative,
even such seemingly extensive data may not, by themselves, give a complete picture of optimization because
combinations of the many underlying variables (Table 1)
lead to an enormous solution space. We comment further
on this aspect below. Existing theory is also ineffective
because sequence coverage has not yet been considered
[12].
Here, we examine optimization from a more focused
mathematical perspective. Our treatment accounts for
sequence errors via the proxy of a variable read covering
count [3,13], but it omits secondary, project-specific
details like software idiosyncrasies [14], instrument-specific biases [15], and alignment issues [16]. The solution
leads to a set of general, though unexpectedly simple optimization principles, which correct some earlier specula-
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Table 1: Variables in a Multi-Genome Variant Detection Project

variable†

meaning

Pv
Pv, min

probability of finding a rare variant
minimum acceptable value of Pv for a project
haploid per-sample sequence redundancy
total, project-wide redundancy
frequency of variant in population
number of samples sequenced in project
minimum read coverings for detection
minimum variant observations to declare discovery

ρ
R

ϕ
σ
τ
N

†Some variables are modified with a "star" superscript to denote
optima, for example σ* is the optimum sample size for a project, ρ*

∗

the optimum per-sample redundancy, and Pv the discovery
probability under optimal conditions.

tion [17] and are useful as first approximations for actual
projects. Because these rules appreciably narrow the solution space, they also offer good starting points for even
more targeted numerical and empirical searches that
might account for secondary effects, if such are deemed
necessary.

Results
The term "rare variant" is routinely taken to mean a rare
allele, although it can also mean a rare SNP genotype.
Take ϕ to be the variant frequency, i.e. the minor allele frequency or the rare homozygous genotype frequency, as
appropriate. We assume the TGP convention whereby
samples are sequenced separately to uniform depths [6,7],
instead of being pooled first. The general theory then
encompasses the multiple-genome population sequencing problem and its subsequent design optimization.
Analytical Characterization of Discovery in Multiple
Genomes
Theorem 1 (Allele Variants). Let DA be the event that a
rare allele is detected, i.e. found by the investigator in a
sequenced diploid genome sample. Its probability is

P(D A ) = φ P(C) ( 2 − φ P(C) ) ,

(1)

where
τ −1

P(C) = 1 −

∑
k =0

k

1 ⎛ ρ ⎞ −ρ / 2
⎜ ⎟ e
k! ⎝ 2 ⎠

(2)

is the coverage probability of spanning the allele's
genomic position on a chromosome with at least τ
sequence reads. Let σ independent, randomly-selected
samples each be sequenced uniformly to haploid depth ρ.
Then, if K is the random variable representing the number
of samples the variant is found in and if N is the minimum number of observations necessary to declare the var-
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iant as being "discovered", the discovery event is defined
as K ≥ N and its probability is
σ

Pv (K ≥ N ) =

⎛σ ⎞

∑ ⎜⎝ k ⎟⎠ P (D
k

A)

[ 1 − P(D A ) ]σ − k .

k=N

(3)
Theorem 2 (Genotype Variants). The probability of DG,
the event that a rare genotype is detected in a sample, is

P(D G ) = φ P 2(C),

(4)

and its discovery probability is again given by Eq. 3, except
where DG, replaces DA.
Statement of the Optimization Problem
Variant discovery is a constrained optimization problem
[18], which can be stated as follows. Given the biological
parameter ϕ and project-specific design parameters R, σ, τ,
Pv, min, and N, maximize the objective function Pv, subject
to both the equality constraint

R = σ ⋅ ρ,

(5)

into Eq. 2 allows us to write a constrained form of the coverage probability, which in turn furnishes constrained
expressions for the probabilities of events DA and DG. It is
expedient at this point to switch from the event-based
notation of probability used up until now to the Eulerian
(functional) convention for the calculus-based aspect of
optimization. Specifically, let fτ, iwith i ∈ {A, G} represent
the now-constrained probabilities of DA and DG. (A
detailed explanation of the switch in notation appears in
"Mathematical Preliminaries".) We now state the following important optimization conditions.
Theorem 3 (Optimal Conditions). The optimum
number of samples in a multiple-genome variation
project for N = 1 is governed by the differential equation

ln(1 − fτ ,i ) −

(6)

In practical terms, we want to most efficiently discover a
variant at the lowest possible cost, as represented by R.
Although the problem is framed in terms of finding a single variant, actual projects are apt to be specified according to discovering a certain average number of rare
variants. These scenarios are equivalent, as Eq. 6 also
quantifies the expected fraction of variants that will be
found in the project. For example, Pv, min = 0.95 indicates
finding 95%, on average, of the variants occurring at some
value of ϕ.
Optimizing for Single and Double Variant Observations
Leaving aside the optimization of ρ versus σ for a
moment, the least obvious of the project-specific parameters to specify is arguably N. Higher values may exceed the
actual number of instances in the sample set, resulting in
a priori failure of the project. We will therefore concentrate
on the experimentally relevant special cases N = 1 and N
= 2. The former is clearly a minimum requirement, while
the latter serves to better discern between a rare population variant and a SNP that is unique to an individual
sample (a "private SNP").

Because we have an explicitly-defined equality constraint
in the form of Eq. 5, the number of design variables can
be reduced by one [18]. Specifically, substituting ρ = R/σ

(7)

and for N = 2 by the differential equation

ln(1 − fτ ,i ) +

fτ ,i
+
1+(σ −1) fτ ,i

⎡
σ −1
σ −1
−
⎢
⎢⎣ 1+(σ −1) fτ ,i 1− fτ ,i

and to the auxiliary constraint

Pv ≥ Pv ,min .

∂f
σ
⋅ τ ,i = 0,
1− fτ ,i ∂σ

⎤ ∂fτ ,i
= 0.
⎥
⎦⎥ ∂σ

(8)

In particular, the roots of these equations in σ indicate
maxima in Pv for rare alleles and genotypes. Each setting
of the independent variables has one such optimum, σ*,
which is necessarily a global optimum.

Discussion
Finding rare variants is clearly an important aspect of both
population and medical genetics [19]. The discovery process was not feasible before the advent of NGIs, but is now
being actively prototyped through efforts like the TGP
[6,7] and will likely become more routine in the future.
This eventuality motivates examination of the problem
from a general perspective, similar in spirit to theoretical
treatments of single genomes [20]. The following sections
report on both some of the broad trends across the design
variable spectrum, as well as optimal conditions for the
important special cases of N = 1 and N = 2.
General Trends
Fig. 1 shows Pv versus σ for variants appearing at 1% frequency for thresholds of N = 1 and τ = 2. The latter
appears to have emerged as the de facto choice to better
control for sequencing errors [3,13]. Aside from the
expected trend that performance improves as more data
are gathered, the curves show two notable properties.
First, σ*, the sample size at which the maximum Pv occurs,
increases with the project redundancy. This dependence
means that a project cannot generally be optimized by
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Probability of discovering variants at ϕ = 1% as a function of sample size for N = 1 and τ = 2. The single square
datum represents the TGP pilot project at R = 360×. Circles
indicate maxima for each curve.
selecting σ in advance of other factors. Put another way,
outright specification of σ almost certainly assures that
the discovery process will not be optimal. We expand further upon this point below.
Fig. 1 also shows that curves are not symmetric with
respect to σ*. The rate of drop-off of Pv for a given projectwide redundancy is much more severe for σ <σ*, implying
that it is better to err in sequencing too many samples
rather than too few. It is interesting to examine one of the
TGP sequencing pilot phases in this context, which specifies 2× data collection for each of σ = 180 samples [6,7].
Here, R = 2·180 = 360, which is one of the curves plotted
in Fig. 1. Using the above thresholds, this design yields Pv
≈ 61%, whereas the optimal configuration returns Pv ≈
66% for only about 100 samples. Despite using almost
twice as many samples as is optimal, this design remains
relatively good, precisely because of the non-symmetric
behavior.
Constant Sample-Size Designs and the Stalling Effect
The above discussion suggests that investigators should
consider abandoning the idea of choosing σ outright. An
earlier projection offers an interesting case study to further
illustrate this point. Gibbs [17] postulated that σ = 2,000
samples would be a good way of discovering extremely
rare variants occurring at 0.05%. (This number may simply have been an expeditious choice, as further details
were not specified, nor was there any description of how
this prediction was made.) Fig. 2 shows the implications
of such a σ-based design. As R increases, σ* marches to the
right on the abscissa, eventually passing through the preselected σ = 2,000 at around R = 7,000. It continues right-

3000

4000

5000

6000

sample size

Gibbs'
τdiscover
Figure
= 2 scenario
2extremely
[17]rare
of using
alleles,
a fixed
ϕ = 2,000
0.0005,
unit
under
sample
N =size
1 and
to
Gibbs' scenario [17]of using a fixed 2,000 unit sample
size to discover extremely rare alleles, ϕ = 0.0005,
under N = 1 and τ = 2. This hypothetical project is plotted
for 5,000 ≤ R ≤ 100,000 and shows the conspicuous "stalling"
effect that occurs under increasingly non-optimal conditions.

ward, leaving our fixed sample datum in the left-side wake
of the optimum (σ <σ*, as mentioned above), where the
associated probability is now heavily penalized. In fact,
the probability stalls at a value of roughly Pv ≈ 0.85,
regardless of the amount of additional data poured into
the project.
Although this stalling effect may initially seem counterintuitive, its explanation is quite straightforward. If we
hold σ fixed while letting R increase without bounds, then
ρ also grows without bounds (Eq. 5). In the limit, each
sample will be perfectly sequenced, i.e. P(C) → 1 in Eq. 2.
Discovery is then simply a function of whether or not the
variant is present in the original sample set. If so, it is
absolutely certain to be discovered. The corresponding
probabilities are then simple special cases of the model in
Thms. 1 and 2. For example, for N = 1 observation of a
rare allele we find

Pv (K ≥ 1)

constant σ ,
R→∞

~ 1 − e −2φσ ,

(9)

which is asymptotically identical to what is obtained if
coverage is not considered at all [5]. The basic problem
associated with constant sample-size designs is immediately apparent in this equation. Given small ϕ, the exponential term decays very slowly and can only be
compensated for by increasing σ. The challenge, of course,
is to do this such that Pv attains a maximum.
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The population model in Thms. 1 and 2 improves matters
considerably, furnishing Pv explicitly in terms of (τ, R, σ,
ϕ, N). One could march through every combination of
these variables, evaluating Pv for each, and log maxima
that attain given levels of Pv, min. Though this approach
would be enormously more efficient than naïve bruteforce simulation, the calculations needed to adequately
survey the floating-point "continuum" of the real-valued
variables remain basically infeasible. Consequently, we
still might not expect to discern any latent general laws.
The Weak Optimization Problem
We resort instead to Thm. 3, whose roots for N = 1 and N
= 2 represent optimal sample sizes, σ*. Let us first describe
some unexpected properties found among the independent variables. These are important in that they furnish a
direct solution to what might be called the weak optimization problem. This is the proposition that relaxes the condition defined by Pv, min. In effect, weak optimization

provides the optimal probability, Pv∗ , subject to a predetermined R rather than a given Pv, min > 0.
Fig. 3 shows σ* versus R for representative parameter settings. Data collapse onto curves according to variant type.
In each case, σ* = σ*(R, τ) and σ* ∝ R. These observations, coupled with σ* = R/ρ* from Eq. 5 then imply
σ*(R, τ) = R/ρ*(τ). In other words, ρ* is only a function
of τ (Table 2). This is quite a significant finding because it
immediately establishes the best sample redundancy for a
project. In essence, this observation indicates that optimizable designs for rare variants are based on constant
values of ρ rather than constant values of σ [17].

Table 2: Constants Associated with Optimum Designs

rare variant

τ

ρ*(τ)

genotype
genotype
allele

1
2
2

2.5
6.4
3.6

allele

1

special case, see Eq. 10

†See

λτ†

β τ†

0.512
0.690
0.537

2.5
6.4
1.8

Eqs. 14, 15, 16

We emphasize that the numbers in Table 2 are not based
on first-principles and are not strictly encoded in the governing equations. Rather, they are fortuitous empiricisms,
restricted to the parameter values that characterize rarevariant projects. Fig. 4 demonstrates that, while ρ* does
indeed only depend upon τ up to allele frequencies of
about 1%, it becomes a more complicated function of
additional variables for higher frequencies.
Remarks on the Special Case of τ = 1 for Rare Alleles
The case of τ = 1 is conspicuously absent for rare alleles in
Figs. 3 and 4 because its optimum sample size is not finite.
Unlike the other cases, Pv approaches its maximum as σ →
∞, for example

Pv (K ≥ 1)

constant R,
σ →∞

~ 1 − e −φ R .

(10)

Here, we have the seemingly contradictory implication
that we should spread a finite amount of sequence
resources over the largest number of samples, each of
which will then have a vanishingly small ρ. Mathemati-

4

optimal sample size (thousands)

Remarks on Optimization Methods
We commented above that empirical prototyping and
numerical simulation are unlikely to give complete
insights to the general optimization problem because of
the size of the solution space. Consider that the relationship between two parameters requires only a single curve
on an X-Y plot, three parameters require a family of curves
on one plot, four a textbook of family-type plots, and so
forth. Richard Bellman, who developed the optimization
technique of dynamic programming, called this phenomenon the "curse of dimensionality". Table 1 shows that we
have 8 variables in our particular problem, however, even
this is somewhat misleading because it does not consider
the probabilistic nature of the problem. That is, Pv can
only be established as an expected value through a sufficient number of repeated trials for each particular combination of the independent variables. This is the basic tactic
used in simulation.
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genotypes, tau = 2

variant

τ

N

C

allele
allele
genotype
genotype
genotype
genotype

2
2
1
1
2
2

1
2
1
2
1
2

10.0
15.8
14.7
23.3
27.8
44.1

6
5
4

N = 1, all Pvals
N = 2, Pval = 0.1
N = 2, Pval = 0.5
N = 2, Pval = 0.95

"rare" variants

alleles, tau = 2

3
2

0.0001

genotypes, tau = 1
0.001

0.01

0.1

variant frequency (phi)

for
Figure
rare
each4variants
value
of τ within
conventional
ρ*, is essentially
range ofconstant
ϕ ≤ 1%
Optimum
redundancy
perthe
sample,
Optimum redundancy per sample, ρ*, is essentially
constant for each value of τ within the conventional
range of ϕ ≤ 1% for rare variants.

cally speaking, the rate by which the per-sample f1, A
decreases precisely offsets the favorable rate of increasing
sample size, whereby Pv does not asymptotically vanish.
However, there will usually be good secondary reasons for
limiting σ in practice, e.g. cost of sample procurement.
Moreover, conditions approach the limiting value rather
quickly, for example setting ρ = R/σ ≤ 0.1 brings Pv very
close to the expression in Eq. 10. R is the main factor governing discovery under these conditions and its value can
be calculated for a desired Pv by simply inverting Eq. 10.
Optimal Designs for Single and Double Variant
Observations
The weak solution specifies constants of ρ* (Table 2),
which simultaneously imply σ* for any choice of R. These
properties subsequently fix certain relationships within
the general problem, so that optimization for a desired Pv,
min in Eq. 6 reduces to the task of solving directly for ϕ (see
Methods). Fig. 5 shows the resulting optimal designs for τ
= 2, a setting characteristic of recent projects [3,13].
Results are plotted for Pv, min = 95%, the same threshold set
by the TGP. All curves show a special kind of log-log relationship between ϕ and R* in which the slope is -1. In
other words, optimal designs can be expressed as a family
of log-log curves having the form ϕ R* = C(N, τ, Pv, min),
where C is a so-called optimization coefficient for each combination of the variables. Of course, knowing C immediately enables one to compute R* and subsequently σ* =
R*/ρ* for a desired ϕ, which is of enormous practical
value for project design. Table 3 shows C for the configurations having well-defined optimum redundancies,
although we note that Eq. 10 also follows this form, having C = 3.0. R* is indicative of the total resources a project

requires, so C is also useful in comparing relative costs.
For example, requiring two observations of a rare allele
instead of just one would only be, somewhat counterintuitively, about 60% more expensive if both schemes
were to be done optimally.
Consider the example of the TGP, whose sizable ad hoc
design effort was already mentioned above. For N = τ = 2
at the 95% level, Table 3 indicates C = 15.8. Assuming 1%
rare allele discovery, optimal processing calls for roughly
440 samples sequenced to 3.6× each, for a project total of
R = 1580×. Given the long-standing convention of specifying ρ in whole units, these results largely confirm the
TGP design, though in a more precise fashion. That is,
TGP has only winnowed the sample size to 400-500 per
population cluster, with each sample sequenced to 4×
[6,7]. The associated Pv curve is relatively flat in 400 ≤ σ ≤
500, but this imprecision, coupled with a round value of
ρ, still imposes a degree of cost liability. For instance, on
the outer end, the project would expend 4·500 = 2000×
in data, roughly 25% more than that required for 95%
confidence. Project modifications are readily analyzed, for
total redundancy (thousands of folds)

optimum redundancy per sample

Table 3: Optimization Coefficients for 95% Discovery
Probability

N = 1 observation
N = 2 observations
100
genotypes

alleles
10

1
0.0001

0.001

0.01

variant frequency (phi)

requiring
rare
Log-log
Figure
genotypes
plot
5 at least
of optimum
and
two
alleles
read
designs,
atcoverings
probabilities
R* vs.
(τ ϕ
=, of
2)
for95%
discovering
when
Log-log plot of optimum designs, R* vs. ϕ, for discovering rare genotypes and alleles at probabilities of
95% when requiring at least two read coverings (τ =
2).
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example, reaching alleles down to ϕ = 0.5% would simply
require doubling the project: about 880 samples with R =
3160×. Analysis of genotypes is now similarly trivial.

Conclusion
Sequence variation is often called the "currency" of genetics [4] and whole-genome sequence variation projects,
enabled by continuing advances in technology, will likely
become both increasingly important and routine in biomedical research. Although finding common occurrences
is no longer considered to be very difficult, rare ones
remain challenging because of the significantly larger
amounts of data that must be gathered. Process optimization has to be considered much more carefully here. We
have reported a general, though remarkably simple set of
optimization principles based on analyzing the population sequencing problem. Results largely confirm the
design of a special case, that of the TGP, but also permit
immediate analysis of a much broader set of possible
project requirements. Derivation of optimal conditions
for even higher N and/or τ would be a mechanical, albeit
not entirely trivial extension of the mathematics shown
here, but the experimental feasibility of such designs for
future projects remains unclear.
Population structure is another consideration, as rare variants are likely to be associated with particular geographic
regions and their sub-populations [4]. A few issues are relevant here. First, some studies target the variation underlying specific phenotypes [21], but variant discovery
projects do not place strong preference on the kinds of
variation that are sought. Second, ρ* is not a function of
rareness (Fig. 4), meaning that latent population-related
differences in frequency will not ruin optimality. One
should simply treat each desired sub-population separately, making no differential adjustments to per-sample
redundancies. This strategy assures discovery of population-specific variants and, incidentally, is precisely what
the TGP is following.

Methods
Mathematical Preliminaries
This section expands on some of the mathematical esoterica involved in establishing the theory.
Chain Rule
This principle enables one to find the derivative of a function that itself depends on another function [22]. In
essence, it establishes a product rule for the respective
derivatives. For example, if y = z3 and z = x2 + 1, then dy/dx
= dy/dz·dz/dx = 3z2·2x = 6x(x2 + 1)2. Chain Rule is used in
the logarithmic differentiation process described below.

http://www.biomedcentral.com/1471-2164/10/485

Independently and Identically Distributed (IID)
This term means that all random variables in a collection
are independent of one another, i.e. they have no mutual
influences or relationships, and that each has the same
probability as all the others [23]. Coin flipping is a simple
example. The current flip is not influenced by past ones,
nor does it influence future ones, and each flip has the
same probability of showing, say, "heads". This concept is
the basis of ultimately establishing the binomial nature of
Pv in Theorem 1.
Logarithmic Differentiation
This mathematical device employs the Chain Rule (see
above) to differentiate functions whose forms render
them difficult to handle using more basic rules. Proof of
Theorem 3 (below) requires this treatment because the
independent variable being differentiated against appears
in the exponent. An illustrative example having precisely
the same issue is y = ex, which is readily shown by this procedure to be its own derivative. Applying Chain Rule to
the logarithmic form, ln y = x, yields y-1·dy/dx = 1, from
which dy/dx = y = ex immediately follows.
Notation
This aspect is complicated by the fact that the theory straddles two different branches of mathematics: probability
and calculus. In the former case, notation is primarily concerned with specifying configurations of events, while in
the latter, Euler's convention is used to describe functional
dependence on a set of independent variables. This necessitates a change in notation as we move from the probabilistic discovery model in Thms. 1 and 2 to the calculusbased optimization process in Thm. 3.

Substituting the constraint in Eq. 5, ρ = R/σ, into Eq. 2, we
can write the constrained form of the coverage probability
as
τ −1

1−

∑
k =0

k

1 ⎛ R ⎞ − R /(2σ )
,
⎜
⎟ e
k ! ⎝ 2σ ⎠

(11)

which now depends upon τ, R, and σ. In turn, this expression is substituted into Eqs. 1 and 4 to obtain constrained
probabilities for events DA and DG, respectively, with
dependence now extending to ϕ, as well. From here on, let
us consider these event probabilities simply as mathematical functions. For example, f1, G is the expression obtained
by setting τ = 1 in Eq. 11, squaring it, and multiplying by
ϕ, i.e. it is the constrained probability of the event DG originally introduced in Eq. 4. Under this notation, we can
then easily represent all such functions universally by writing them in a form fτ, i = fτ, i (ϕ, R, σ), where i ∈ {A, G}.
This is the convention we follow in both Thm. 3 (above)
and its proof (below).
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Roots of a Function
Roots are values of the independent variable which cause
a function to vanish, i.e. to be equal to zero. For example,
y = x2 - 9 can be factored as y = (x + 3) (x - 3), showing that
x = ±3 are the roots for which y = 0. This concept is relevant
to the proof of Theorem 3 (below) because maxima
within the Pv family of functions occur at roots in σ of the
first derivatives. Roots play a similar role in solving Eqs.
15 and 16.
Proofs of Theorems 1 to 3
Theorem 1: Let Aj and Cj be the events, respectively, that
an allele variant exists on chromosome j in a sample at
location x and that x is spanned (covered) by at least τ
sequence reads. The detection event is DA = (A1 ∩ C1) ∪
(A2 ∩ C2). Given the presumed IID (see "Mathematical
Preliminaries") nature of alleles and coverage with respect
to chromosomes, ϕ = P(A1) = P(A2) and P(C) = P(C1) =
P(C2), from which Eq. 1 follows directly. Eq. 2 is a corollary of diploid covering theory [24]. Finally, with respect
to any given sample, DA is a Bernoulli process: an allele is
either detected, or it is not. Given uniform ρ for each sample and the random selection of presumably independent
genomes, the process is IID. The distribution of detected
variants is then binomial [23], from which Eq. 3 follows
directly.

Setting the resulting derivatives equal to zero gives the corresponding characteristic equations

⎡
∂f ⎤
∂Pv
σ
⋅ τ ,i ⎥ = 0
= ( Pv − 1 ) ⎢ ln(1 − fτ ,i ) −
f
1
−
∂σ
⎢⎣
τ ,i ∂σ ⎥⎦
and

⎡
fτ ,i
∂Pv
+
= ( Pv − 1 ) ⎢ ln(1 − fτ ,i ) +
1+(σ −1) fτ ,i
∂σ
⎢⎣
⎛
σ −1
σ −1
−
⎜⎜
(
)
1
1
σ
− fτ ,i
+
−
f
1
,
τ
i
⎝

⎞ ∂fτ ,i
⎟⎟
⎠ ∂σ

⎤
⎥=0
⎥⎦

for N = 1 and N = 2, respectively. In general, Pv ≠ 1 in either
case, so the conditions must instead be satisfied by the
terms in square brackets. Eqs. 7 and 8 follow directly.
The fact that there is only a single, global optimum, σ*,
for each case is a consequence of Pv being a unimodal
function in σ. In general, Pv vanishes monotonically for σ
>σ* because P(C) → 0, and consequently fτ, i → 0, as σ is
increased under finite values of R. The exception is f1, A, for
which Pv asymptotically approaches a maximum (Eq. 10).
Solution of the General Optimization Problem

Theorem 2: Let G represent the existence of a rare genotype in a sample. Since both alleles must be discerned, the
detection event is DG = G ∩ C1 ∩ C2. Because coverage of
x is not a function of whether the genotype is actually
present and vice versa, G and C1 ∩ C2 are independent,
whereby Eq. 4 follows directly.
Theorem 3: The optimization problem is cast by substituting the single-sample detection probability, fτ, i (see
"Mathematical Preliminaries"), into the project-wide discovery probability, Pv(K ≥ N) in Eq. 3. Noting that fτ, i and
Pv are both functions of σ (among other variables), but
omitting the functional notation, this process gives

Pv (K ≥ 1) = 1 − ⎡⎣ 1 − fτ ,i ⎤⎦

σ

Pv (K ≥ 2) = Pv (K ≥ 1) − σ fτ ,i ⎡⎣ 1 − fτ ,i ⎤⎦

(12)
σ −1

Optimal conditions are described by constants of ρ*,
which can be substituted into the single-sample probability to obtain an optimized f τ∗,i . For N = 1, we can then
derive the following expression, valid for both alleles and
genotypes, directly from Eq. 12

φ=

β /R
1− ⎡⎣ 1− Pv ,min(K ≥1) ⎤⎦ τ
λτ

(14)

,

where constants λτ and βτ are given in Table 2. This equation describes the relationship between ϕ and R under
optimal conditions when given user-specified values of τ
and Pv, min. For N = 2, we cannot readily obtain an explicit
optimization rule from Eq. 13. Instead, we cast the relationship as a root-finding problem in ϕ for genotypes as

(13)

for the special cases of interest, N = 1 and N = 2, respectively.
Roots in σ of the first derivatives of these equations are a
necessary condition in identifying the extrema of Pv[22].
Their forms require us to use logarithmic differentiation.
(This procedure and the concept of roots are both outlined in the "Mathematical Preliminaries" section above.)

⎡
⎛
⎞
⎢ 1 + ⎜ R − 1 ⎟ φλτ
⎜ ρ ∗(τ )
⎟
⎢
⎝
⎠
⎣

⎤
∗
⎥ [ 1 − φλτ ] R / ρ (τ )−1
⎥
⎦
+ Pv ,min (K ≥ 2) − 1 = 0
(15)

and for alleles as
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⎛
⎢1 + ⎜
⎢
⎜⎝
⎢⎣

⎤

⎞
R / βτ − 2
R
⎟ 2 − φλ τ φλ τ ⎥ ⎡⎣ 1 − φλ τ ⎤⎦
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1
⎥
∗
ρ (τ ) ⎟⎠
⎥⎦

(

)

+ Pv,min ( K ≥ 2) − 1 = 0.

1.
2.

3.

(16)
That is, given τ, R, and Pv, min the values of ϕ under which
the process is optimal are the roots of Eqs. 15 and 16.
Derivatives and Numerical Method
Eqs. 7 and 8 depend upon partial derivatives of fτ, i. For
rare alleles and genotypes, i.e. i ∈ {A, G}, we follow standard rules of differentiation [22] to obtain

⎞
∂f 2, A φ R 2 − R /(2σ ) ⎛ ⎡
R ⎞ − R /(2σ ) ⎤
⎛
− 1 ⎟⎟
φ ⎢1 − ⎜ 1 +
=
e
e
⎜
⎟
⎥
⎜
2σ ⎠
∂σ
⎝
⎦
2σ 3
⎝ ⎣
⎠
(17)
∂f1,G φ R − R / σ
=
e
− e − R /(2σ )
2
∂σ
σ

(

4.
5.
6.
7.
8.
9.
10.
11.

)

(18)
12.

∂f 2,G φ R 2 ⎡ − R /σ ⎛
R ⎞
− R /(2σ ) ⎤ .
=
⎜⎝ 1+
⎟⎠ − e
⎢e
⎥
3
σ
∂σ
2
⎦
2σ ⎣

13.

(19)
Note that an equation for f1, A is absent because the case of
τ = 1 for rare alleles does not have a well-defined optimum (Eq. 10).

14.

Eqs. 7, 8, 15, and 16 all depend upon the concept of finding the roots of an equation. (See "Mathematical Preliminaries" above.) Although none is readily factorable, they
can be solved by the bisection algorithm, which is
straightforward to apply, has reasonably good convergence behavior, and is extremely robust [25].
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